These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 15057920)

  • 1. Diagnosis, management, and treatment of hepatitis C.
    Strader DB; Wright T; Thomas DL; Seeff LB;
    Hepatology; 2004 Apr; 39(4):1147-71. PubMed ID: 15057920
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of hepatitis C. The 2002 French consensus.
    Dhumeaux D; Marcellin P; Lerebours E
    Gut; 2003 Dec; 52(12):1784-7. PubMed ID: 14633963
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis, management, and treatment of hepatitis C: an update.
    Ghany MG; Strader DB; Thomas DL; Seeff LB;
    Hepatology; 2009 Apr; 49(4):1335-74. PubMed ID: 19330875
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hepatitis C: a systematic review.
    Kohli A; Shaffer A; Sherman A; Kottilil S
    JAMA; 2014 Aug; 312(6):631-40. PubMed ID: 25117132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.
    Afdhal N; Zeuzem S; Kwo P; Chojkier M; Gitlin N; Puoti M; Romero-Gomez M; Zarski JP; Agarwal K; Buggisch P; Foster GR; Bräu N; Buti M; Jacobson IM; Subramanian GM; Ding X; Mo H; Yang JC; Pang PS; Symonds WT; McHutchison JG; Muir AJ; Mangia A; Marcellin P;
    N Engl J Med; 2014 May; 370(20):1889-98. PubMed ID: 24725239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofosbuvir for previously untreated chronic hepatitis C infection.
    Lawitz E; Mangia A; Wyles D; Rodriguez-Torres M; Hassanein T; Gordon SC; Schultz M; Davis MN; Kayali Z; Reddy KR; Jacobson IM; Kowdley KV; Nyberg L; Subramanian GM; Hyland RH; Arterburn S; Jiang D; McNally J; Brainard D; Symonds WT; McHutchison JG; Sheikh AM; Younossi Z; Gane EJ
    N Engl J Med; 2013 May; 368(20):1878-87. PubMed ID: 23607594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EASL Recommendations on Treatment of Hepatitis C 2016.
    European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu
    J Hepatol; 2017 Jan; 66(1):153-194. PubMed ID: 27667367
    [No Abstract]   [Full Text] [Related]  

  • 8. EASL Clinical Practice Guidelines: management of hepatitis C virus infection.
    European Association for Study of Liver
    J Hepatol; 2014 Feb; 60(2):392-420. PubMed ID: 24331294
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.
    Kwo PY; Lawitz EJ; McCone J; Schiff ER; Vierling JM; Pound D; Davis MN; Galati JS; Gordon SC; Ravendhran N; Rossaro L; Anderson FH; Jacobson IM; Rubin R; Koury K; Pedicone LD; Brass CA; Chaudhri E; Albrecht JK;
    Lancet; 2010 Aug; 376(9742):705-16. PubMed ID: 20692693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.
    Hézode C; Forestier N; Dusheiko G; Ferenci P; Pol S; Goeser T; Bronowicki JP; Bourlière M; Gharakhanian S; Bengtsson L; McNair L; George S; Kieffer T; Kwong A; Kauffman RS; Alam J; Pawlotsky JM; Zeuzem S;
    N Engl J Med; 2009 Apr; 360(18):1839-50. PubMed ID: 19403903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection.
    Kallman J; O'Neil MM; Larive B; Boparai N; Calabrese L; Younossi ZM
    Dig Dis Sci; 2007 Oct; 52(10):2531-9. PubMed ID: 17406828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Study of Performance of a Nanoribbon Biosensor, Sensitized with Aptamers and Antibodies, upon Detection of Core Antigen of Hepatitis C Virus.
    Ivanov YD; Malsagova KA; Goldaeva KV; Pleshakova TO; Kozlov AF; Galiullin RA; Shumov ID; Popov VP; Abramova IK; Ziborov VS; Petrov OF; Dolgoborodov AY; Archakov AI
    Micromachines (Basel); 2023 Oct; 14(10):. PubMed ID: 37893383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms of Resistance to Direct-Acting Antiviral (DAA) Drugs for the Treatment of Hepatitis C Virus Infections.
    Izhari MA
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh.
    Rahman MA; Islam MM; Ali ME; Islam MA; Afroze F; Hossain MS; Rus'd AA
    Glob Med Genet; 2023 Sep; 10(3):199-204. PubMed ID: 37565062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020.
    Baliashvili D; Blumberg HM; Gandhi NR; Averhoff F; Benkeser D; Shadaker S; Gvinjilia L; Turdziladze A; Tukvadze N; Chincharauli M; Butsashvili M; Sharvadze L; Tsertsvadze T; Zarkua J; Kempker RR
    PLoS Med; 2023 May; 20(5):e1004121. PubMed ID: 37141386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of muscle strength and quality in North African patients with chronic hepatitis B: A pilot case control study.
    Bergaoui J; Latiri I; Chaouch H; Ben Abdallah J; Mrad S; Maatamri W; Letaief A; Ben Saad H
    Libyan J Med; 2023 Dec; 18(1):2204564. PubMed ID: 37096573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy.
    Ozdogan E; Arikan C
    Clin Exp Pediatr; 2023 Mar; 66(3):110-124. PubMed ID: 36550776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RT-LAMP-Based Molecular Diagnostic Set-Up for Rapid Hepatitis C Virus Testing.
    Sharma S; Thomas E; Caputi M; Asghar W
    Biosensors (Basel); 2022 May; 12(5):. PubMed ID: 35624599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical Biosensors for Diagnostics of Infectious Viral Disease: A Recent Update.
    Sharma A; Mishra RK; Goud KY; Mohamed MA; Kummari S; Tiwari S; Li Z; Narayan R; Stanciu LA; Marty JL
    Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis-Induced Porphyria: Are Direct-Acting Antiviral Agents the Way of the Future?
    John JJ; Sterling RK
    ACG Case Rep J; 2021 May; 8(5):e00581. PubMed ID: 34007857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.